Destination Wealth Management Astrazeneca PLC Transaction History

Destination Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $48,144 - $54,564	-1,200 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$35.49 - $43.02 $9,298 - $11,271	-262 Reduced 17.92%	1,200 $49,000
Q4 2018 Feb 05, 2019	BUY	$36.86 - $41.49 $9,657 - $10,870	262 Added 21.83%	1,462 $56,000
Q3 2018 Nov 07, 2018	BUY	$34.76 - $39.72 $27,808 - $31,776	800 Added 200.0%	1,200 $47,000
Q2 2018 Jul 31, 2018	BUY	$34.55 - $37.05 $13,819 - $14,819	400 New	400 $14,000

1,367

475M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.